Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer - AstraZeneca (NASDAQ:AZN), BioNTech (NASDAQ:BNTX)

According to findings from a new U.K. study, along with reducing the risk of severe disease and hospitalization, COVID-19 vaccines can also lower the odds of having long-term COVID-19 symptoms.
"We found that the odds of having symptoms for 28 days or more after post-vaccination infection were approximately halved by having two vaccine doses," citing researchers, reported CNN.
The study result suggests that the risk of long COVID is reduced in individuals who have received double vaccination.
From institutions in the U.S. and the U.K., the researchers analyzed self-reported data from adults in the U.K. who shared any COVID-19 symptoms using a mobile phone app.
The data included more than 1.2 million adults who reported receiving the first dose of a vaccine. Among them, 0.5% tested positive for an infection after receiving that first dose.
Among nearly 1 million adults who reported receiving a second dose of vaccine, only 0.2% or 2,370 tested positive.
Compared with no vaccination, vaccination was associated with reduced odds of hospitalization or having more than five symptoms in the first week of illness following a first or second dose.
The researchers found reduced odds of long-term symptoms lasting 28 days or more following a second vaccine dose.
Photo by Johaehn from Pixabay